Santen Pharmaceutical Co (JP:4536) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Santen Pharmaceutical Co. has successfully repurchased 3,729,200 common shares totaling over 6.29 billion yen as part of its share buyback program implemented in November 2024. The buyback is a strategic move to enhance shareholder value, with a maximum target of 5 million shares and a budget of 10 billion yen set by the company.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue